l carnitine tartrate molecular formula 2.1-1 The structural of L-carnitine (Ill. by Ida S. R Carnitine L-carnitine Molecule. Structural Chemical
Description
Manufactured in a facility using ingredients derived from milk (including lactose), soybeans, peanuts, other nuts, cereals containing gluten, eggs, crustaceans, fish
[DOI] [PMC free article] [PubMed] [Google Scholar] 251.Martinez-Vicente M., Talloczy Z., Wong E., Tang G., Koga H., Kaushik S., de Vries R., Arias E., Harris S., Sulzer D., et al
17 A dose of 100 g/kg of ()-huperzine A (1) administered to mice inhibits AChE of 2.5% 0.9% (means SEM, n = 21)
-
Complications of Carnitine Deficiency Syndrome include organ damage to the liver, heart, brain, and various skeletal muscles of the body, including heart muscle weakness (cardiomyopathy) Brain injury may present severe brain dysfunction (encephalopathy), irreversible learning problems, and mental retardation Another complication includes problems with the metabolism of the body, especially relating to fat and energy metabolism
Mutations in SLC27A4 (the gene encoding FATP4) cause autosomal recessive congenital ichthyosis prematurity syndrome (OMIM #608649)
